{
    "symbol": "SGFY",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-08 03:24:04",
    "content": " And so bringing all of those things together, all of that rich data without a doubt, has not only extreme benefit for our existing clients and the risk models that we underwrite, but we believe we'll continue to have big play in the future with life sciences, real-world evidence and clinical trial delivery across these various populations, both on the identification side, we can find that needle in the haystack, but we also can bring healthcare to folks and not make them come into a facility to help execute and keep a trial on the right track."
}